Age at first cardiovascular diagnosis and risk of subsequent cardiovascular events in patients with different types of cardiovascular disease - Scorecard - MDSpire
Advertisement
Age at first cardiovascular diagnosis and risk of subsequent cardiovascular events in patients with different types of cardiovascular disease
Clinical Scorecard: Impact of Initial Cardiovascular Diagnosis Age on Future Cardiovascular Events Across Various Disease Types
At a Glance
Category
Detail
Condition
Cardiovascular disease (CVD) including coronary artery disease (CAD), cerebrovascular disease (CeVD), peripheral artery disease (PAD), and abdominal aortic aneurysm (AAA)
Key Mechanisms
Age at first CVD diagnosis influences risk of subsequent cardiovascular events; risk factors include smoking, hypertension, hypercholesterolaemia contributing to atherosclerosis
Target Population
Patients with a recent (<12 months) first diagnosis of CAD, CeVD, PAD, or AAA
Care Setting
Secondary prevention and management in cardiovascular specialty clinics or tertiary care centers
Key Highlights
Younger age at first CVD diagnosis is associated with lower risk of subsequent cardiovascular events in patients with CeVD and women with PAD/AAA.
No significant association between age at diagnosis and future events was found in patients with CAD or men with PAD/AAA.
Findings emphasize the need for more intensive secondary prevention in younger patients with CAD and men with PAD/AAA.
Guideline-Based Recommendations
Diagnosis
Include patients with first CVD diagnosis within 12 months for accurate age-related risk assessment.
Classify CVD subtypes precisely: CAD, CeVD, PAD, and AAA using clinical and imaging criteria.
Management
Implement intensive secondary prevention strategies particularly in younger patients with CAD and men with PAD/AAA.
Personalize treatment plans based on CVD subtype and patient sex to optimize risk reduction.
Monitoring & Follow-up
Long-term follow-up (median 11 years) to monitor for subsequent cardiovascular events including MI, stroke, limb events, and cardiovascular death.
Adjust monitoring frequency based on age at diagnosis and CVD subtype.
Risks
Higher age at diagnosis increases risk of subsequent events in CeVD patients and women with PAD/AAA.
Younger patients with CAD and men with PAD/AAA remain at significant risk despite age.
Patient & Prescribing Data
5057 patients from the UCC-SMART cohort with recent first CVD diagnosis
Younger patients with CeVD and women with PAD/AAA may have better prognosis; however, younger patients with CAD and men with PAD/AAA require more aggressive secondary prevention.
Clinical Best Practices
Stratify patients by CVD subtype and sex when assessing risk and planning secondary prevention.
Focus on modifiable risk factors such as smoking cessation, blood pressure control, and lipid management across all age groups.
Ensure early and intensive intervention in younger patients with CAD and men with PAD/AAA to reduce lifetime cardiovascular risk.
by Martijn M Pieterse, Martin Teraa, Manon G van der Meer, Ynte M Ruigrok, Mike J L Peters, Ilonca Vaartjes, Frank L J Visseren, Jannick A N Dorresteijn, on behalf of the UCC-SMART Study Group
